BCR-ABL1 (BCR-ABL Fusion Protein)
BCR-ABL1
Constitutively active tyrosine kinase from Philadelphia chromosome t(9;22) in CML.
الوظيفة
Imatinib was the first targeted TKI, transforming CML from fatal to manageable disease.
BCR-ABL1
Constitutively active tyrosine kinase from Philadelphia chromosome t(9;22) in CML.
Imatinib was the first targeted TKI, transforming CML from fatal to manageable disease.